Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.

Cheng A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R.

Pacing Clin Electrophysiol. 2012 Aug;35(8):912-8. doi: 10.1111/j.1540-8159.2012.03441.x. Epub 2012 Jun 5.

PMID:
22670627
2.

Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.

Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB.

J Am Coll Cardiol. 1999 Oct;34(4):1082-9.

4.
5.

The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.

Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH 2nd, Sethuraman B, Dettmer MM, Rosenbaum DS; ABCD Trial Investigators.

J Am Coll Cardiol. 2009 Feb 10;53(6):471-9. doi: 10.1016/j.jacc.2008.08.077.

6.

The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.

Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.

Ital Heart J. 2005 Mar;6(3):272-80.

PMID:
15875520
7.

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators.

Circulation. 2004 Mar 23;109(11):1386-91. Epub 2004 Mar 1.

9.

Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.

Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB.

J Cardiovasc Electrophysiol. 2003 May;14(5):492-8.

PMID:
12776866
10.

Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.

PMID:
17413310
11.

Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.

Yuge M, Niwano S, Moriguchi M, Sasaki T, Hirasawa S, Imaki R, Sato D, Izumi T.

Circ J. 2006 Mar;70(3):268-72.

12.

Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.

Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H.

Int J Cardiol. 2006 Mar 8;107(3):360-8.

PMID:
16503259
13.

[Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].

Piekarz J, Rydlewska A, Majewski J, Lelakowski J.

Pol Merkur Lekarski. 2012 Jun;32(192):368-73. Polish.

PMID:
22891561
14.

T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers.

Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ.

J Cardiovasc Electrophysiol. 1998 Dec;9(12):1258-68.

PMID:
9869525
15.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

16.

Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators.

Steinberg JS, Beckman K, Greene HL, Marinchak R, Klein RC, Greer SG, Ehlert F, Foster P, Menchavez E, Raitt M, Wathen MS, Morris M, Hallstrom A.

J Cardiovasc Electrophysiol. 2001 Sep;12(9):996-1001.

PMID:
11573709
17.

Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.

Zaman S, Narayan A, Thiagalingam A, Sivagangabalan G, Thomas S, Ross DL, Kovoor P.

Pacing Clin Electrophysiol. 2014 Jul;37(7):795-802. doi: 10.1111/pace.12391. Epub 2014 Mar 25.

PMID:
24666010
19.

Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.

Sadarmin PP, Wong KC, Rajappan K, Bashir Y, Betts TR.

Europace. 2014 Nov;16(11):1575-9. doi: 10.1093/europace/euu054. Epub 2014 Mar 25.

PMID:
24668515
20.

The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.

Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.

Europace. 2004 Sep;6(5):400-6. Erratum in: Europace. 2005 Jan;7(1):91.

PMID:
15294264

Supplemental Content

Support Center